Said the same myself in prior posts. Its a common assumption on here a deal will only progress on FDA approving the 2x2. I can see numerous scenarios where that is not a factor at all. Its what we want as investors of course. Doesn't make it a pre-requisite to a Chinese deal for example.
Arguably quite the opposite. If I am a Chinese suitor, convinced of the merits having done my due dilligence already, I want to strike a deal whilst PAR is looking a little listless. If PAR gets 2x2 FDA confirmation, it would be a more brazen PR and co. at the negotiating table.
Here's hoping Paul "I've been touting a partnership deal for five years" Rennie finally pulls a deal out of the hat, 2x2 FDA confirmation or otherwise.
Said the same myself in prior posts. Its a common assumption on...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33599 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 65498 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |